6-Morpholin-4-yl-nicotinic acid tert-butyl ester, 95.0%, 1g

2-(dimethylamino)butanoic acid, 95.0%, 10g

1,2-Bis(4-chlorophenyl)ethane-1,2-dione, 95.0%, 100g

3-Nitro-2-(trifluoromethyl)benzonitrile, 97.0%, 1g

Reaktionsgefäße 1,5 ml, steril, mit Deckel, konisch, 500 Stück

1,3,4-Thiadiazole-2,5-diamine, 95.0%, 250mg

Methyl 6-bromo-1-methyl-1H-indazole-4-carboxylate, 98%, 100mg

2-Methyl-4,6-dihydroxypyrimidine, 97.0%, 1g

2-[7-Fluoro-2-(oxan-4-yl)-1H-1,3-benzodiazol-1-yl]acetic acid, 1g

ethyl N-methyl-beta-alaninate, 95.0%, 250mg

Diphenyldimethylsilane, 97%, 250mg

Fmoc-3-aminomethyl-phenylacetic acid, 99.0%, 1g

(4-Pyrrol-1-yl-phenyl)-acetic acid, 95.0%, 500mg